Neuraminidase Inhibitor Market Scope And Analysis

  • Report Code : TIPRE00016378
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Neuraminidase Inhibitor Market Growth Analysis by 2031

Buy Now

Neuraminidase Inhibitor Market Report Neuraminidase Inhibitor Market Size and Share Neuraminidase Inhibitor Market Scope and Analysis

Neuraminidase Inhibitor Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Indication
  • Influenza Virus A
  • Influenza Virus B
By Drug Type
  • Zanamivir
  • Oseltamivir
  • Peramivir
  • Laninamivir
By Route of Administration
  • Parenteral
  • Oral
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Strides Consumer LLC
  • BioCryst Pharmaceuticals Inc
  • Teva Pharmaceuticals Industries Ltd
  • NATCO Pharma Limited
  • Alvogen
  • Amneal Pharmaceuticals LLC
  • Macleods Pharmaceuticals Ltd
  • F Hoffmann La Roche Ltd
  • GlaxoSmithKline Plc
    		•